semaglutide binge eating disorder case report GLP-1RAs and Obesity Associated with Disorders Eating disorders are substantial disturbances

Mechanism: activates both GIP and GLP-1 receptors, reducing hunger, slowing gastric emptying, increasing satiety, improving glucose regulation and fat metabolism

Routine Laboratory Monitoring: While semaglutide doesn't require specific blood test monitoring beyond standard diabetes care, informing your primary care physician ensures appropriate interpretation of glucose, HbA1c, and other metabolic parameters

Altered plasma levels of glucagon, GLP-1 and glicentin during OGTT in adolescents with obesity and Type 2 diabetes

Your provider reviews the full safety profile with you before you begin and stays available through the portal

According to the CDC, one in five children now has an obesity diagnosisnearly 15 million children and teens nationwide

We really wanted to provide the best evidence and best ways to change practice in the home with this tool, Pathak said